American International Group Inc. Purchases 16,213 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

American International Group Inc. lifted its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 46.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 51,086 shares of the company’s stock after acquiring an additional 16,213 shares during the period. American International Group Inc.’s holdings in LifeStance Health Group were worth $466,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Ameritas Investment Partners Inc. raised its position in shares of LifeStance Health Group by 56.6% in the 1st quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company’s stock worth $56,000 after acquiring an additional 2,016 shares in the last quarter. Squarepoint Ops LLC bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $62,000. Point72 Hong Kong Ltd bought a new position in shares of LifeStance Health Group during the second quarter valued at approximately $63,000. Price T Rowe Associates Inc. MD bought a new position in shares of LifeStance Health Group during the third quarter valued at approximately $75,000. Finally, Balyasny Asset Management L.P. bought a new position in shares of LifeStance Health Group during the first quarter valued at approximately $84,000. Institutional investors own 76.98% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. decreased their target price on shares of LifeStance Health Group from $10.00 to $8.00 and set a “neutral” rating for the company in a research note on Friday.

LifeStance Health Group Trading Up 0.8 %

Shares of NASDAQ LFST opened at $6.17 on Friday. The firm’s 50 day moving average price is $6.30 and its 200-day moving average price is $7.73. LifeStance Health Group, Inc. has a 52-week low of $4.22 and a 52-week high of $9.59. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market cap of $2.34 billion, a PE ratio of -11.87 and a beta of 1.08.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Wednesday, November 8th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.10). The business had revenue of $262.90 million during the quarter, compared to the consensus estimate of $255.18 million. LifeStance Health Group had a negative net margin of 18.72% and a negative return on equity of 12.59%. The business’s revenue was up 20.8% compared to the same quarter last year. During the same period last year, the company posted ($0.11) earnings per share. On average, equities research analysts expect that LifeStance Health Group, Inc. will post -0.44 EPS for the current fiscal year.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Kevin Michael Mullins sold 113,333 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $6.61, for a total value of $749,131.13. Following the completion of the transaction, the insider now owns 4,917,283 shares of the company’s stock, valued at approximately $32,503,240.63. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, insider Ann Varanakis sold 5,661 shares of the firm’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $7.60, for a total transaction of $43,023.60. Following the sale, the insider now owns 168,441 shares of the company’s stock, valued at approximately $1,280,151.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Kevin Michael Mullins sold 113,333 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $6.61, for a total transaction of $749,131.13. Following the sale, the insider now directly owns 4,917,283 shares in the company, valued at approximately $32,503,240.63. The disclosure for this sale can be found here. Insiders have sold 212,237 shares of company stock valued at $1,389,099 over the last ninety days. Insiders own 8.50% of the company’s stock.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.